These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18307742)

  • 1. Influence of blood sampling procedure on plasma concentrations of matrix metalloproteinases and their tissue inhibitors.
    Rossignol P; Cambillau M; Bissery A; Mouradian D; Benetos A; Michel JB; Plouin PF; Chatellier G; Jacob MP
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):464-9. PubMed ID: 18307742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Matrix metalloproteinases and their inhibitors in lung cancer with malignant pleural effusion].
    Moche M; Hui DS; Huse K; Chan KS; Choy DK; Scholz GH; Gosse H; Winkler J; Schauer J; Sack U; Hoheisel G
    Pneumologie; 2005 Aug; 59(8):523-8. PubMed ID: 16110415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin affects matrix metalloproteinases and tissue inhibitors of metalloproteinases circulating in peripheral blood.
    Mannello F; Jung K; Tonti GA; Canestrari F
    Clin Biochem; 2008 Dec; 41(18):1466-73. PubMed ID: 18926810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP.
    Becher N; Hein M; Uldbjerg N; Danielsen CC
    Reprod Biol Endocrinol; 2008 Sep; 6():45. PubMed ID: 18826601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure.
    Wilson EM; Gunasinghe HR; Coker ML; Sprunger P; Lee-Jackson D; Bozkurt B; Deswal A; Mann DL; Spinale FG
    J Card Fail; 2002 Dec; 8(6):390-8. PubMed ID: 12528092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Gindzienska-Sieskiewicz E; Chwiecko J
    J Rheumatol; 2006 Aug; 33(8):1523-9. PubMed ID: 16881109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased concentration of tissue-degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease.
    Rosemar A; Ivarsson ML; Börjesson L; Holmdahl L
    Scand J Gastroenterol; 2007 Feb; 42(2):215-20. PubMed ID: 17327941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with HIV-1 infection and syphilis or neurosyphilis.
    Tsai HC; Ye SY; Kunin CM; Lee SS; Wann SR; Tai MH; Shi MH; Liu YC; Chen YS
    Cytokine; 2011 May; 54(2):109-16. PubMed ID: 21354815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity.
    Dietmann A; Helbok R; Lackner P; Issifou S; Lell B; Matsiegui PB; Reindl M; Schmutzhard E; Kremsner PG
    J Infect Dis; 2008 Jun; 197(11):1614-20. PubMed ID: 18700258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases in isolated hypercholesterolemia.
    Malik J; Stulc T; Ceska R
    Int Angiol; 2005 Sep; 24(3):300-3. PubMed ID: 16158043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors.
    Fondard O; Detaint D; Iung B; Choqueux C; Adle-Biassette H; Jarraya M; Hvass U; Couetil JP; Henin D; Michel JB; Vahanian A; Jacob MP
    Eur Heart J; 2005 Jul; 26(13):1333-41. PubMed ID: 15827062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer.
    Sørensen NM; Schrohl AS; Jensen V; Christensen IJ; Nielsen HJ; Brünner N
    Scand J Gastroenterol; 2008; 43(2):186-91. PubMed ID: 18224564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents.
    Belo VA; Souza-Costa DC; Lana CM; Caputo FL; Marcaccini AM; Gerlach RF; Bastos MG; Tanus-Santos JE
    Clin Biochem; 2009 Jul; 42(10-11):984-90. PubMed ID: 19358835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of anticoagulants on the activity of gelatinases.
    Castellazzi M; Tamborino C; Fainardi E; Manfrinato MC; Granieri E; Dallocchio F; Bellini T
    Clin Biochem; 2007 Nov; 40(16-17):1272-6. PubMed ID: 17904541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal analysis of metalloproteinases, tissue inhibitors of metalloproteinases and clinical parameters in gingival crevicular fluid from periodontitis-affected patients.
    Pozo P; Valenzuela MA; Melej C; Zaldívar M; Puente J; Martínez B; Gamonal J
    J Periodontal Res; 2005 Jun; 40(3):199-207. PubMed ID: 15853964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of matrix metalloproteinases activity in acute myocardial infarction.
    Papadopoulos DP; Moyssakis I; Makris TK; Poulakou M; Stavroulakis G; Perrea D; Votteas VE
    Eur Cytokine Netw; 2005 Jun; 16(2):152-60. PubMed ID: 15941687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum matrix metalloproteinase and tissue inhibitor of metalloproteinase concentrations in infertile women achieved pregnancy following IVF-ET.
    Shibahara H; Suzuki T; Kikuchi K; Hirano Y; Suzuki M
    Am J Reprod Immunol; 2005 Oct; 54(4):186-92. PubMed ID: 16135009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMP and TIMP alterations in asymptomatic and symptomatic severe recurrent carotid artery stenosis.
    Sapienza P; Borrelli V; di Marzo L; Cavallaro A
    Eur J Vasc Endovasc Surg; 2009 May; 37(5):525-30. PubMed ID: 19297218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of pre-analytical and analytical factors on soluble CD40L measurements.
    Varo N; Nuzzo R; Natal C; Libby P; Schönbeck U
    Clin Sci (Lond); 2006 Nov; 111(5):341-7. PubMed ID: 16856875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of matrix metalloproteinases, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aortas with dilatative pathology.
    Lesauskaite V; Epistolato MC; Castagnini M; Urbonavicius S; Tanganelli P
    Hum Pathol; 2006 Aug; 37(8):1076-84. PubMed ID: 16867871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.